Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Search by expertise, name or affiliation
Benefits of minimal residual disease negativity in the therapy of chronic lymphocytic leukemia.
Neil E. Kay
Contribution to journal
Dive into the research topics of 'Benefits of minimal residual disease negativity in the therapy of chronic lymphocytic leukemia.'. Together they form a unique fingerprint.